Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -290.63x is 68% above its 5-year average of -895.72x, near the high end of its 5-year range (-60781.00x–-149.24x).
As of the fiscal period ended Monday, March 31, 2025. 70.71% above its 12-month average of -992.33x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2025 (2025-03-31): -290.63x.
INTEREST COVERAGE RATIO
-290.63x
INTEREST COVERAGE RATIO AVG TTM
-992.33x
INTEREST COVERAGE RATIO AVG 3Y
-21511.38x
INTEREST COVERAGE RATIO AVG 5Y
-895.72x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+70.71%
CURRENT VS 3Y AVG
+98.65%
CURRENT VS 5Y AVG
+67.55%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-4458.89%
vs the sector median at left
Twist Bioscience Corporation
Market Cap
$10.72B
Interest Coverage Ratio
-290.63x
TTM Avg
-992.33x
3Y Avg
-21511.38x
5Y Avg
-895.72x
Market Cap
$10.69B
Interest Coverage Ratio
12.68x
TTM Avg
10.82x
3Y Avg
8.80x
5Y Avg
10.61x
Market Cap
$10.87B
Interest Coverage Ratio
48.95x
TTM Avg
43.59x
3Y Avg
27.00x
5Y Avg
27.00x
Market Cap
$10.97B
Interest Coverage Ratio
6.83x
TTM Avg
6.50x
3Y Avg
6.73x
5Y Avg
9.55x
Market Cap
$10.37B
Interest Coverage Ratio
N/A
TTM Avg
39.63x
3Y Avg
39.63x
5Y Avg
39.63x
Market Cap
$10.38B
Interest Coverage Ratio
-2.28x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.14B
Interest Coverage Ratio
N/A
TTM Avg
67.41x
3Y Avg
66.08x
5Y Avg
407.22x
Market Cap
$10.13B
Interest Coverage Ratio
4.07x
TTM Avg
9.27x
3Y Avg
11.38x
5Y Avg
10.77x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Twist Bioscience Corporation (TWST) | $10.72B | -290.63x | -992.33x | -21511.38x | -895.72x |
| Universal Health Services, Inc. (UHS)vs › | $10.69B | 12.68x | 10.82x | 8.80x | 10.61x |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $10.87B | 48.95x | 43.59x | 27.00x | 27.00x |
| 10x Genomics, Inc. (TXG)vs › | $10.54B | N/A | N/A | N/A | N/A |
| The Cooper Companies, Inc. (COO)vs › | $10.97B | 6.83x | 6.50x | 6.73x | 9.55x |
| Globus Medical, Inc. (GMED)vs › | $10.37B | N/A | 39.63x | 39.63x | 39.63x |
| ImmunityBio, Inc. (IBRX)vs › | $10.38B | -2.28x | N/A | N/A | N/A |
| Align Technology, Inc. (ALGN)vs › | $10.14B | N/A | 67.41x | 66.08x | 407.22x |
| Molina Healthcare, Inc. (MOH)vs › | $10.13B | 4.07x | 9.27x | 11.38x | 10.77x |
| Bio-Techne Corporation (TECH)vs › | $11.34B | 46.60x | 29.31x | 24.60x | 23.61x |
Interest Coverage
-290.6x
Debt/Equity
0.21
Current Ratio
2.67
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-03-31 | -290.63x |
| 2024-12-31 | -1443.50x |
| 2024-09-30 | -1242.86x |
| 2023-09-30 | -50112.00x |
| 2023-06-30 | -60781.00x |
| 2023-03-31 | -30818.50x |
| 2022-12-31 | -44630.00x |
| 2022-09-30 | -2187.35x |
| 2022-03-31 | -2096.62x |
| 2021-12-31 | -2151.54x |
| 2021-09-30 | -479.65x |
| 2021-06-30 | -601.69x |
| 2021-03-31 | -400.04x |
| 2020-12-31 | -277.91x |
| 2020-09-30 | -167.60x |
| 2020-06-30 | -155.78x |
| 2020-03-31 | -149.24x |
| 2019-12-31 | -225.12x |
| 2019-09-30 | -109.61x |
| 2019-06-30 | -88.43x |
| 2019-03-31 | -77.24x |
| 2018-12-31 | -65.80x |
| 2018-09-30 | -51.05x |
| 2018-06-30 | -51.89x |
| 2018-03-31 | -52.42x |
| 2017-12-31 | -61.36x |
| 2017-09-30 | -67.03x |
